目前干细胞移植治疗心肌梗死的研究已取得了重大进展。虽然干细胞具有持续自我更新并无限增殖的能力，且能够跨谱系接受不同表型，但移植中和移植后干细胞的大量死亡影响了干细胞疗法的有效性。造成移植细胞死亡现象的原因有很多，如宿主炎症反应、外界机械损伤、移植细胞对环境难以适应等。现阶段已有大量研究表明通过对干细胞预处理能够提高干细胞存活率，从而提高干细胞治疗心肌梗死的有效性。在本文中作者对当前的各种干细胞的预处理方法进行综述，旨在为解决干细胞移植后大量丢失这一难题提供参考。

[1] SANGANALMATH S K,BOLLI R.Cell therapy for heart failure:a comprehensive overview of experimental and clinical studies,current challenges,and future directions[J].Circ Res,2013,113(6):810-834.
[2] 黎叶飞,盛祖龙,姚玉宇,等.骨髓间充质干细胞不同移植途径治疗急性心肌梗死的研究[J].东南大学学报:医学版,2011,30(5):687-691.
[3] JEONG H,YIM H W,CHO Y,et al.The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction[J].Stem Cell Res Ther,2013,4(4):82.
[4] MURRY C E,JENNINGS R B,REIMER K A.Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium[J].Circulation,1986,74(5):1124-1136.
[5] 杨帆,姚玉宇,马根山.激肽-激肽释放酶系统在心血管疾病发展中的重要作用[J].东南大学学报:医学版,2013,32(5):612-617.
[6] SIMKHOVICH B Z,PRZYKLENK K,KLONER R A.Role of protein kinase C in ischemic "conditioning":from first evidence to current perspectives[J].J Cardiovasc Pharmacol Ther,2013,18(6):525-532.
[7] HEADRICK J P,ASHTON K J,ROSE'MEYER R B,et al.Cardiovascular adenosine receptors:expression,actions and interactions[J].Pharmacol Ther,2013,140(1):92-111.
[8] GROSS G J,AUCHAMPACH J A.Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs[J].Circ Res,1992,70(2):223-233.
[9] SUZUKI Y,KIM H W,ASHRAF M,et al.Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas[J].Am J Physiol Heart Circ Physiol,2010,299(4):H1077-1082.
[10] TAGHAVI S,GEORGE J C.Homing of stem cells to ischemic myocardium[J].Am J Transl Res,2013,5(4):404-411.
[11] SAINI U,GUMINA R J,WOLFE B,et al.Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation[J].J Cell Biochem,2013,114(11):2612-2623.
[12] TANG Y L,ZHU W,CHENG M,et al.Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression[J].Circ Res,2009,104(10):1209-1216.
[13] PEART J N,HEADRICK J P.Sustained cardioprotection:exploring unconventional modalities[J].Vascul Pharmacol,2008,49(2-3):63-70.
[14] DEBSKA G,KICINSKA A,SKALSKA J,et al.Opening of potassium channels modulates mitochondrial function in rat skeletal muscle[J].Biochim Biophys Acta,2002,1556(2-3):97-105.
[15] GONZLEZ G,ZALDVAR D,CARRILLO E,et al.Pharmacological preconditioning by diazoxide downregulates cardiac L-type Ca(2+) channels[J].Br J Pharmacol,2010,161(5):1172-1185.
[16] SATO T,LI Y,SAITO T,et al.Minoxidil opens mitochondrial K(ATP) channels and confers cardioprotection[J].Br J Pharmacol,2004,141(2):360-366.
[17] COSTA A D,QUINLAN C L,ANDRUKHIV A,et al.The direct physiological effects of mitoK(ATP) opening on heart mitochondria[J].Am J Physiol Heart Circ Physiol,2006,290(1):H406-415.
[18] WANG X,FISHER P W,XI L,et al.Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection[J].J Mol Cell Cardiol,2008,44(1):105-113.
[19] CUI X,WANG H,GUO H,et al.Transplantation of mesenchymal stem cells preconditioned with diazoxide,a mitochondrial ATP-sensitive potassium channel opener,promotes repair of myocardial infarction in rats[J].Tohoku J Exp Med,2010,220(2):139-147.
[20] AFZAL M R,HAIDER H K H,IDRIS N M,et al.Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling[J].Antioxid Redox Signal,2010,12:693-702.
[21] MAHBOUBI K,BIEDERMANN B C,CARROLL J M,et al.IL-11 activates human endothelial cells to resist immune-mediated injury[J].J Immunol,2000,164(7):3837-3846.
[22] LI W,MA N,ONG L L,et al.Bcl-2 engineered MSCs inhibited apoptosis and improved heart function[J].Stem Cells,2007,25(8):2118-2127.
[23] BRUNT K R,WU J,CHEN Z,et al.Ex vivo Akt/HO-1 gene therapy to human endothelial progenitor cells enhances myocardial infarction recovery[J].Cell Transplant,2012,21(7):1443-1461.
[24] LU F,ZHAO X,WU J,et al.MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis[J].Int J Cardiol,2013,167(6):2524-2532.
[25] WARD M R,CONNELLY K,VIJAYARAGHAVAN R,et al.eNOS overexpressing bone marrow cells are safe and effective in a porcine model of myocardial regeneration following acute myocardial infarction[J].Cardiovasc Ther,2013,31(6):e72-78.
[26] KANKI-HORIMOTO S,HORIMOTO H,MIENO S,et al.Synthetic vascular prosthesis impregnated with mesenchymal stem cells overexpressing endothelial nitric oxide synthase[J].Circulation,2006,114(1 Suppl):I327-330.
[27] KAUR S,KUMAR T R,URUNO A,et al.Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease:an in vitro study[J].Basic Res Cardiol,2009,104(6):739-749.
[28] SCHUH A,KONSCHALLA S,KROH A,et al.Effect of SDF-1 α on endogenous mobilized and transplanted stem cells in regeneration after myocardial infarction[J].Curr Pharm Des,2013,Jun 18.
[29] SCHENK S,MAL N,FINAN A,et al.Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor[J].Stem Cells,2007,25(1):245-251.
[30] ALVES G D,PAZZINE M,GOMES de MACEDO BRAGA L M,et al.Molecular mapping of the regenerative niche in a murine model of myocardial infarction[J].Int J Mol Med,2012,29(3):479-484
[31] WANG K,ZHAO X,KUANG C,et al.Overexpression of SDF-1α enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway[J].PLoS One,2012,7(9):e43922.
[32] LIU X B,CHEN H,CHEN H Q,et al.Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation[J].J Zhejiang Univ Sci B,2012,13(8):616-623.
[33] SHUJIA J,HAIDER H K,IDRIS N M,et al.Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair[J].Cardiovasc Res,2008,77(3):525-533.
[34] JIANG S,HAIDER H K H,IDRIS N M,et al.Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair[J].Circ Res,2006,99(7):776-784.